In the present work we synthesized some novel α, β-unsaturated ketones with an aim to obtain some new potent antibacterial and antioxidant agents. The α, β-unsaturated ketones were synthesized by base catalysed Claisen-Schmidt condensation of ketones having α, α' hydrogens with various aldehydes. Three new series of α, β-unsaturated ketones were synthesized by reacting γ-t-butylcyclohexanone, γ-phenylcyclohexanone and γ-ethylcyclohexanone with different substituted benzaldehydes. The classes of the synthesized compounds are:
INTRODUCTION
The search for 'better medicines for a better world' is a never-ending process to help the suffering mankind from dreadful and fatal ailments. The process of new drug discovery is driven by the requirement to synthesize novel molecules having good potential with high therapeutic index 1 . α, β-Unsaturated ketones also known as chalcones have recently attracted the attention of many medicinal chemists owing to the ease of their synthesis and wide array of pharmaceutical and medicinal applications. Chalcones are abundant in the plant kingdom 2 . They are considered to be the precursors of flavanoids and isoflavanoids. Chemically they consist of two aromatic rings joined by a three carbon α, β-unsaturated carbonyl system. Synthesis of chalcones is generally accomplished by a simple base catalysed Claisen-Schmidt condensation of a ketone and a suitably substituted aldehyde.
It is now well known that most natural and synthetic chalcones have shown extensive pharmacological activities such as antiprotozoal, antifungal, anti-inflammatory, antileishmanial, nitric oxide inhibition, inhibition of the production of the interleukin-1, anticancer, antibacterial and antioxidant 3 . Keeping in view these diverse therapeutic activities, it was contemplated to synthesize a novel series of chalcones. In the present work attention has been focused on the synthesis of chalcones with different ketone moieties and their antibacterial and antioxidant properties.
Antibacterial Activity
Antimicrobial drugs are the greatest contribution of 20 th century to therapeutics. They are one of the few curative drugs. Their importance is magnified in the developing countries, where infective diseases predominate.
The modern era of chemotherapy was ushered by Domagk in 1935 by demonstrating the therapeutic effect of Prontosil, a sulphonamide dye, in pyogenic infections 4 . Since then numerous classes of antibacterial agents have been discovered, and literally hundreds of drugs are available for use today. With the first successful clinical trial of crude Penicillin (1941) and the requirements of the war time, an explosion of successful activity ensued which continues over 50 years later. In the rapid succession deliberate searches of the metabolic products of a wide variety of soil microbes led to the discovery of streptomycin(1943), chloramphenicol (1947) ,chlortetracycline (1948), neomycin (1949) , erythromycin (1952) and more and this resulted in the age of the miracle drugs 5 . Though thousands of antimicrobial agents are available, the infectious diseases caused by bacteria, fungi, viruses and parasites are still a major threat to public health. The impact is more acute in the developing countries due to non availability of the desired medicines and emergence of widespread drug resistance.
Staphylococcus aureus was reported in 2003 6 . Enterococcus faecium is another superbug found in hospitals. Penicillin-resistant Enterococcus was seen in 1983, Vancomycin-resistant Enterococcus (VRE) in 1987, and Linezolid-resistant Enterococcus (LRE) in the late 1990s 6 . Resistance of Streptococcus pneumoniae to penicillin and other beta-lactams is increasing worldwide 6 . In November 2004, the Center for Disease Control and Prevention (CDC) reported an increasing number of Acinetobacter baumannii bloodstream infections in patients at military medical facilities. Most of these showed multidrug resistance, with a few isolates resistant to all drugs tested 6 .
Until recently, research and development (R&D) efforts have provided new drugs in time to treat bacteria that became resistant to older antibiotics. That is no longer the case. The potential crisis at hand is the result of a marked decrease in industry R&D, and the increasing prevalence of resistant bacteria. Physicians are alarmed by the prospect that effective antibiotics may not be available to treat seriously ill patients in the near future. The resistance problem demands that a renewed effort be made to seek antibacterial agents effective against pathogenic bacteria resistant to current antibiotics 6 . Literature quotes a variety of α, β-unsaturated ketones with various substitutions to have been found active against a number of bacteria, hence these present a potential source to develop the much needed more efficacious antibacterial agents.
Antioxidant Activity
WHO defines health positively as "a state of complete physical, mental, and social well-being and not merely the absence of disease." Foods high in antioxidants are reliably associated with human health and well being 7 . Chronic diseases like diabetes, heart disease, arthritis, cognition diseases and cancer have been linked to "oxidation" of "cellular molecules" such as proteins, lipids and DNA. This is where damaging modified oxygen molecules attach to molecules in cells and cause damage and inflammation. This is why "antioxidants" have received so much media attention because they help to prevent or remove the damaging oxygen molecules from interacting with cellular molecules before they cause damage and lead to disease 8 .
An antioxidant is a molecule capable of slowing or preventing the oxidation of other molecules. Oxidation is a chemical reaction that transfers electrons from a substance to an oxidizing agent. Oxidation reactions can produce free radicals, which start chain reactions that damage cells. Antioxidants terminate these chain reactions by removing free radical intermediates, and inhibit other oxidation reactions by being oxidized themselves 6 .
Although oxidation reactions are crucial for life, they can also be damaging; hence, plants and animals maintain complex systems of multiple types of antioxidants, such as glutathione, vitamin C, and vitamin E as well as enzymes such as catalase, superoxide dismutase and various peroxidases. Low levels of antioxidants, or inhibition of the antioxidant enzymes, causes oxidative stress and may damage or kill cells 6 .
The importance of Antioxidants Free Radicals
In the most scientific of understandings, the body runs on a series of daily, complex, chemical reactions. Our stomach breaks down food. This is used by the various organs to power cellular regeneration. This process occurs in the mitochondria in a series of complex chemical reactions able to occur because of enzymes, a protein or a protinaceous substance. As a byproduct to this key process, known as oxidative metabolism, the mitochondria produce potentially damaging reactive oxygen species 9 .
Oxygen molecules are generally found in pairs and with a full set of outer electrons strongly bond together. However, these reactive oxygen species such as singlet oxygen, superoxide, peroxy radicals, hydroxyl radicals and peroxynitrite has a weak set of bonds, which emits unstable free electron particles, or free radicals. In an attempt to gain stability, free radicals react quickly with surrounding compounds, often "stealing" an electron from the nearest stable molecule. As this displaces the electron of the attacked molecule becomes a free radical starting a process which can cascade to the fatal disruption and damage to a living cell 9 .
Reactions that generate these species are exemplified as follows 10 
Analytical Techniques Physical data
Melting points of the synthesized compounds were determined using Thiele's melting point apparatus and were uncorrected. Thin Layer Chromotography (TLC)
Purity of the compounds was checked by thin layer chromatography using silica gel G as stationary phase and various combinations of ethyl acetate: cyclohexane as mobile phase. The spots resolved were visualized as brown colored spots by using iodine chamber.
Instrumentation
The techniques employed for the characterization of the synthesized compounds were UV spectra, IR spectra, 1 H-NMR spectra, Mass spectra and Elemental analysis.
UV Spectra
The UV spectra of the synthesized compounds were recorded on UV-Visible spectrophotometer (model Shimadzu 8700) using chloroform and the values of wave length (ƛ max) are reported in nm.
Infrared Spectra
The IR spectra of the synthesized compounds were recorded on a Fourier Transform IR spectrometer (model Shimadzu 8700) in the range of 400 -4000 using KBr and the values of ν max are reported in cm -1 . 1 H-NMR Spectra 1 HNMR spectra were recorded on Amx-400 MHz NMR spectrometer and Amx-100 MHz NMR spectrometer using CDCl 3 and chemical shifts (δ) are reported in parts per million downfield from internal reference Tetramethyl silane (TMS). Mass Spectra Mass spectra were recorded on Mass spectrophotometer (model Shimadzu) by LC-MS.
Elemental Analysis
Elemental analysis was performed, and the reports were obtained on Thermo Finnigan flash EA 1112 CHNS analyzer. 
α,α' -Bis(2,3-dichlorobenzylidene)-γ-t-butylcyclohexanone [1a].
An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,3-dichloro benzaldehyde (3.5 g, 0.02 mol) and γ-t-butylcyclohexanone (1.5 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.178-179 0 C, was 83%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,4dichlorobenzaldehyde (3.5 g, 0.02 mol) and γ-t-butylcyclohexanone (1.5 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.196-197 0 C, was 83%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 5-bromo-2methoxybenzaldehyde (4.3 g, 0.02 mol) and γ-t-butylcyclohexanone (1.5 g,mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.138-139 0 C, was 82%. 
An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,4dimethoxybenzaldehyde (3.3 g, 0.02 mol) and γ-t-butylcyclohexanone (1.5 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.190-191 0 C, was 87%. . An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 3,4-dimethoxybenzaldehyde (3.3 g, 0.02 mol) and γ-tbutylcyclohexanone (1.5 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.118-119 0 C, was 82%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,5dimethoxybenzaldehyde (3.3 g, 0.02 mol) and γ-t-butylcyclohexanone (1.5 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.119-120 0 C, was 83%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,4,5trimethoxybenzaldehyde (3.9 g, 0.02 mol) and γ-t-butylcyclohexanone (1.5 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.160-161 0 C, was 75%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,3,4trimethoxybenzaldehyde (3.9 g, 0.02 mol) and γ-t-butylcyclohexanone (1.5 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.122-123 0 C , was 84%. 
An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of p-chlorobenzaldehyde (2.8 g, 0.02 mol) and γ-t-butylcyclohexanone (1.5g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.186-187 0 C, is 90%. . An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of p-ethoxybenzaldehyde (3.0 mL, 0.02 mol) and γ-t-butylcyclohexanone (1.5 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.166-167 0 C, was 88%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,4dichlorobenzaldehyde (3.5 g, 0.02 mol) and γphenylcyclohexanone (1.7 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.119-120 0 C, was 80%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 5-bromo-2-methoxybenzaldehyde (4.3 g, 0.02 mol) and γphenylcyclohexanone (1.7 g, mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.140-141 0 C, was 77%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,4,5trimethoxybenzaldehyde (3.9 g, 0.02 mol) and γphenylcyclohexanone (1.7 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.115-116 0 C, was 78%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of m-chlorobenzaldehyde (2.8 mL, 0.02 mol) and γ-phenylcyclohexanone (1.7 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.127-128 0 C, was 75%. An aqueous solution of sodium hydroxide (10% w/v, 30 mL) was added to a solution of 2,3dimethoxybenzaldehyde (3.3 mL, 0.02 mol) and γphenylcyclohexanone (1.7 g, 0.01 mol) in ethanol (50 mL). The reaction mixture was stirred at 10-20 0 C for 2 hr and left overnight in an ice chest to get a yellow colored solid. The product was filtered, washed with ice-cold water (100 mL) followed by ice-cold ethanol (20 mL), dried and recrystallized from alcohol. The yield of product, m.p.99-100 0 C, was 71 %. 
* (x:y) = Cyclohexane : Ethyl acetate
Antibacterial activity A volume of 25 ml of sterile hot agar medium was poured in each plate and allowed to harden on a level surface. The agar plates were inoculated with 24 hr test cultures by spreading uniformly with sterile cotton swabs. The plates were then allowed to dry in the inverted position in an incubator for 30 min. Afterwards they were removed and bores were made on the medium using sterile borer. A volume of 0.1 mL of test solution was added to the respective bores.
as taken as standard reference. A control having only DMF in the cup was maintained in each plate. The petri plates were kept in the refrigerator at 4 0 C for 15 min for diffusion to take place. Afterwards they were incubated at 37 0 C for 24 hr and zones of inhibition were observed and measured using a scale. Each experiment was carried out in triplicate and the mean diameter of inhibition zone was recorded. .The various antibacterial results of [1a-j] & [2a-h] are shown in the Table 3 , 4 respectively. 
D PPPH solution
A working solution of DPPH having an absorbance of 0.9 at 516 nm was used. This was Prepared by taking 95 µL of stock solution containing 12.9 mg of DPPH in 10 mL of methanol.
Standard solution
Ascorbic acid was used as a standard free radical scavenger. This was prepared by dissolving 50 mg of ascorbic acid in 50 mL of methanol.
Test solution
Test solutions of the compounds (10mg/10mL) were prepared by dissolving them in 1 mL DMSO and volume was made to 10 mL with methanol.
Procedure
To 95 µL DPPH solution in methanol, different concentrations of ascorbic acid were added, and the volumes were made up to 4 mL with methanol. DPPH diluted to 4 mL was taken as blank. Decrease of absorbance in the presence of ascorbic acid was noted down after 15 minutes. Linear regression was applied for concentration and percentage inhibition and EC 50 was calculated. To the different concentrations of test solutions (0.4, 0.8, 1.2, 1.6 mL), 95 µL of DPPH solution was added and volume made up to 4 mL with methanol. Decrease in a b s o r b a n c e of DPPH was noted after 15 minutes. Linear regression was applied for concentration and percentage inhibition and EC 50 was calculated from graph. The antioxidant activity of all the newly synthesized α, β-unsaturated ketones has been evaluated by DPPH method using ascorbic acid as the standard. The EC 50 value for α,α'-bis(2,4,5-trimethoxybenzylidene)-γ-tbutylcyclohexanone [1g] due to DPPH radical scavenging activity is 518 µg/mL. The observations of other results indicate that replacement of 2,4,5trimethoxyphenyl by other groups such as 2,3dichlorophenyl, 2,4-dichlorophenyl, 5-bromo-2methoxyphenyl, 2,4-dimethoxyphenyl, 3,4-dimethoxy, 2,5-dimethoxyphenyl, 2,3,4-trimethoxyphenyl, pchlorophenyl or p-ethoxyphenyl decreases the activity.
The EC 50 value for α,α'-bis(2,4dimethoxybenzylidene)-γ-phenylcyclohexanone [2d] due to DPPH radical scavenging activity is 505 µg/mL. The observations of other results indicate that replacement of 2,4-dimethoxyphenyl by other groups such as 2,3-dichlorophenyl, 2,4-dichlorophenyl, 5bromo-2-methoxyphenyl, 2,5-dimethoxyphenyl, 2,4,5trimethoxyphenyl, m-chlorophenyl or 2,3dimethoxyphenyl decreases the activity.
CONCLUSION:
In the present work we synthesized some novel α, βunsaturated ketones with an aim to obtain some new potent antibacterial and antioxidant agents. The α, β- All the synthesized compounds were screened for their in vitro antibacterial properties against human pathogenic Gram positive and gram-negative bacteria. Ampicillin was used as the standard. The observations reveal that: α,α'-Bis(2,4-dichlorobenzylidene)-γphenylcyclohexanone [2b] shows highest activity against Bacillus subtilis. α,α' -Bis(2,3dichlorobenzylidene)-γ-t-butylcyclohexanone [1a] is most active against Klebsiella pneumonia. All the synthesized compounds were also screened for their antioxidant activity using ascorbic acid as the standard by DPPH method. The observations show that α,α'-
